Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179333 · ClinicalTrials.gov registry record
Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
A clinical trial of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types, sponsored by University of South Florida.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02179333: Completed study of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types, sponsored by University of South Florida.
NCT02179333 is a study of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types that has completed, run by University of South Florida. The registered enrollment target is 30 participants, below the 74-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02179333, a study of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.
Primary Outcome
Assess agreement between raters (inter-rater agreement) and within raters (intra-rater agreement) through the evaluation of STAND total score, subtotals and individual variables using intraclass correlation coefficients (ICCs).
Conditions Studied
Interventions
- OTHER Ataxia rating scale
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-06 |
What the finished NCT02179333 record still lists
NCT02179333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 74-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Friedreich's Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Ataxia rating scale is the first listed.
NCT02179333 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02179333 about?
NCT02179333 is a clinical study titled "Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)". The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.
What is the current status of trial NCT02179333?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2012-10. Estimated completion is 2016-06.
What conditions does trial NCT02179333 study?
This clinical trial studies the following conditions: Friedreich's Ataxia, Spinocerebellar Ataxia - All Sub-types.
What interventions are being tested in trial NCT02179333?
The interventions under investigation include: Ataxia rating scale (OTHER).
Who is sponsoring clinical trial NCT02179333?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02179333 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich's Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers in Friedreich's Ataxia
RECRUITING
-
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
RECRUITING
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
COMPLETED · Phase 1
-
EPI-743 in Friedreich's Ataxia Point Mutations
COMPLETED · Phase 2
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia